Vericel
VCELNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$2.651 B
$51.77 +13.83%
Close of 6 Nov 2026
As of 6 Nov 2026, Vericel (VCEL) has a market capitalization of $2.65B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$276.3M
#2152 by revenue
Earnings
$16.5M
#1922 by earnings
Shares outstanding
51,029,770
Latest filing cover page
P/E ratio
160.5
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 163 →- #29Adma BiologicsADMA$2.94B
- #30Beam TherapeuticsBEAM$2.68B
- #31VericelVCEL$2.65B
- #32Recursion PharmaceuticalsRXRX$2.18B
- #33Hemab TherapeuticsCOAG$2.13B
What if Vericel were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Vericel are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.